An end-to-end service proposition for all stages of your growth and exit
Who We Are
We offer a combination of services to constitute your most beneficial financing mix
About Us
FFUND was founded by a group of experienced entrepreneurs with a common vision to accelerate the translation of innovation in the life science industry. Our goal is to convert years of business and product development experience into an end-to-end solution for our customers. We focus on successfully securing the financing mix, including European non-dilutive funding, equity financing, and deals.
Currently we served over 280 Life Science start-ups, SMEs, and Universities in the EU with a range of consulting services primarily focused on strategic funding and M&A activities. We are on the journey to build an EU-wide network to foster leading innovations in 4 domains: Therapeutics, MedTech, Diagnostics, and Digital Health.
Our Vision
Our vision is to support life science ventures in successfully securing an optimal blend of financing to bring their product to the market and build a healthy company. We do so by providing hands-on financial, business, and fundraising support with our team of serial entrepreneurs and expert consultants. This enables the company or project management team to save time and bring knowledge onboard to maximize the chances of funding, while maintaining focus on the core business activity of developing innovative products for the healthcare system.
In our vision paper, we elaborate on our dedicated solutions and hands-on services to raise and manage funding from external parties and to secure strong license and exit deals.
Area’s of Expertise
“We leverage our scientific and business background to support companies in becoming investor ready, close strong deals and create value.”
Dr. Judith Smit
CEO
“We have experienced the challenges that our clients are faced with and can help them to become successful.”
Dr. Henk Viëtor
CBO
Our Story
Dr. Judith J. Smit (CEO) and Dr. Henk Viëtor (CBO)
The life science sector is experiencing prosperous growth. Numerous new technologies are invented and valorised every year. The demand for translating technologies from the lab bench to the clinic is very high, while the path to success is challenged with many scientific, regulatory and financial hurdles.
At FFUND, we bring over 60 years of combined entrepreneurial experience in the segment to help our clients accelerate their R&D roadmap, with the ambition to enable more technologies to reach the market. We support them as a true “impact partner” with a solid know-how of the sector dynamics, financing opportunities, technical expertise and a network of stakeholders.
We are convinced that a balanced financing mix (non-dilutive, loans and equity) is crucial for a successful life sciences company. FFUND is the partner to unburden our clients with this complex task and secure a successful financing strategy. We are an end-to-end partner, covering our client’s financing need from start-up to commercialization or exit.
Why our clients choose FFUND
Life Sciences experts
As entrepreneurs we understand the Life Science development and funding roadmap by personal experience. We strive to be your sparring partner throughout your growth trajectory and towards a lucrative exit.
Strategy
We know which funding instruments and strategies are best fitted for each development step. Based on your product development needs and vision for the future, together we can determine the most appropriate funding and exit strategy for your company.
Partnerships
Successful life sciences companies use a complex mix of equity and non-dilutive funding instruments. Non-dilutive funding reduces the dilution of shares, while it provides an excellent opportunity to establish valuable partnerships and external validation of the company and technology.
Specialists
FFUND boutique consulting is specialized to help innovators in the life sciences to plan, secure and coordinate the optimal financing mix and fund their project from start-up to successful exit. We save your valuable time and increase the chance success.
280+
Clients served worldwide
€500M +
Funding raised across all stages of innovation growth
Global Network
Acces to network of global investors, large Pharma/Med Tech players and innovation ecosystems
260+
Clients in the EU
Our Team
Meet our experts
We bring the right people together to challenge established thinking and drive transformation.
